Champions Oncology, Inc.CSBRNASDAQ
LOADING
|||
EBITDA Over Time
Trending higher, above historical average.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$6.29M
↑ 548% above average
Average (9y)
$-1.41M
Historical baseline
Range
High:$6.29M
Low:$-10.20M
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2025 | $6.29M | +216.3% |
| 2024 | $-5.41M | -161.6% |
| 2023 | $-2.07M | -169.1% |
| 2022 | $3.00M | +48.4% |
| 2021 | $2.02M | +374.7% |
| 2020 | $-735000.00 | -187.8% |
| 2019 | $837000.00 | +177.3% |
| 2018 | $-1.08M | +83.8% |
| 2017 | $-6.70M | +34.3% |
| 2016 | $-10.20M | - |